BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19760932)

  • 21. [Concentrations of pro-inflammatory cytokines IFN-gamma, IL-6, IL-12 and IL-15 in serum and cerebrospinal fluid in patients with neuroborreliosis undergoing antibiotic treatment].
    Pancewicz SA; Kondrusik M; Zajkowska J; Grygorczuk S
    Pol Merkur Lekarski; 2007 Apr; 22(130):275-9. PubMed ID: 17684925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis.
    Umehara Y; Kudo M; Nakaoka R; Kawasaki T; Shiomi M
    Hepatogastroenterology; 2006; 53(72):879-82. PubMed ID: 17153445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.
    Sawada K; Kusugami K; Suzuki Y; Bamba T; Munakata A; Hibi T; Shimoyama T
    Am J Gastroenterol; 2005 Jun; 100(6):1362-9. PubMed ID: 15929771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa.
    Zwolinska-Wcislo M; Brzozowski T; Budak A; Kwiecien S; Sliwowski Z; Drozdowicz D; Trojanowska D; Rudnicka-Sosin L; Mach T; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2009 Mar; 60(1):107-18. PubMed ID: 19439813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study.
    Bossa F; Latiano A; Rossi L; Magnani M; Palmieri O; Dallapiccola B; Serafini S; Damonte G; De Santo E; Andriulli A; Annese V
    Am J Gastroenterol; 2008 Oct; 103(10):2509-16. PubMed ID: 18721243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of high dose oestrogen therapy on circulating inflammatory markers.
    Wilson R; Spiers A; Ewan J; Johnson P; Jenkins C; Carr S
    Maturitas; 2009 Mar; 62(3):281-6. PubMed ID: 19231116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal inflammation in the terminal ileum of ulcerative colitis patients: endoscopic findings and cytokine profiles.
    Yamamoto T; Maruyama Y; Umegae S; Matsumoto K; Saniabadi AR
    Dig Liver Dis; 2008 Apr; 40(4):253-9. PubMed ID: 18243079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study.
    Federico A; Tuccillo C; Grossi E; Abbiati R; Garbagna N; Romano M; Tiso A; Blanco Cdel V; Loguercio C
    Eur Rev Med Pharmacol Sci; 2009; 13(4):285-93. PubMed ID: 19694343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection.
    Chow SS; Craig ME; Jones CA; Hall B; Catteau J; Lloyd AR; Rawlinson WD
    Cytokine; 2008 Oct; 44(1):78-84. PubMed ID: 18703348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating cytokine levels compared to pain in patients with fibromyalgia -- a prospective longitudinal study over 6 months.
    Wang H; Moser M; Schiltenwolf M; Buchner M
    J Rheumatol; 2008 Jul; 35(7):1366-70. PubMed ID: 18528959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis.
    Biasco G; Zannoni U; Paganelli GM; Santucci R; Gionchetti P; Rivolta G; Miniero R; Pironi L; Calabrese C; Di Febo G; Miglioli M
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):469-71. PubMed ID: 9184782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitis.
    Sato S; Chiba T; Nakamura S; Matsumoto T
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1467-72. PubMed ID: 25968585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis.
    Shimada M; Iwase H; Tsuzuki T; Hirashima N; Kobayashi K; Hibino Y; Watanabe H; Ryuge N; Ando T; Goto H; Yagi Y; Tsujikawa T; Andoh A
    Ther Apher Dial; 2008 Oct; 12(5):368-73. PubMed ID: 18937719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intrathecal therapy with 1 500 UI of antitetanic serum and 1.5 g of intravenous metronidazole: prognosis of tetanus in hospitalized patients in Togo].
    Wateba M; Diop S; Nichols S; Patassi A; Adjo S; Gbadamassi G; Tidjani O
    Sante; 2008; 18(3):125-9. PubMed ID: 19359232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The combination of polymorphisms within MCP-1 and IL-1beta associated with ulcerative colitis.
    Li KS; Wang BY; Liu SY; Yao SP; Guo L; Mao DW
    Int J Immunogenet; 2009 Jun; 36(3):135-9. PubMed ID: 19392835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
    Mawdsley JE; Jenkins DG; Macey MG; Langmead L; Rampton DS
    Am J Gastroenterol; 2008 Jun; 103(6):1460-9. PubMed ID: 18510607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age as a clinical predictor of relapse after induction therapy in ulcerative colitis.
    Jang ES; Lee DH; Kim J; Yang HJ; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Kim N; Jung HC; Song IS
    Hepatogastroenterology; 2009; 56(94-95):1304-9. PubMed ID: 19950781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
    Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.